Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-04-04FDA Approved: METHADOSE DISPERSIBLE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for METHADOSE DISPERSIBLE (methadone hydrochloride) by SpecGx LLC, introducing a dispersible formula…
-
CLINICAL_TRIALS research · 2007-03-27Clinical Trial Update: Buprenorphine and Integrated HIV Care Evaluation [Phase 4]
Phase 4 clinical trial evaluating buprenorphine with integrated HIV care for individuals with opioid use disorder and HIV infection/AIDS; cu…
-
FDA approval · 2007-01-10FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application from SpecGx LLC for Methadone Hydrochloride (generic), confirming approval of a supplemental update …
-
FDA approval · 2006-12-07FDA Approved: DISKETS — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for DISKETS (methadone hydrochloride) submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2006-11-14Clinical Trial Update: Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia [Phase 4]
This Phase 4 clinical trial evaluated the effects of ketamine on precipitated opioid withdrawal under general anesthesia in individuals with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-09-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride from SpecGx LLC.
-
CLINICAL_TRIALS trial_result · 2006-08-23Clinical Trial Update: Treatment of Polydrug-Using Opiate Dependents During Withdrawal [Phase 4]
Phase 4 clinical trial update on treating polydrug-using individuals with opioid dependence during withdrawal; the study has completed.